Depot‐medroxyprogesterone acetate (DMPA) and risk of liver cancer

• Main Authors: J. G. Mati, P. Kenya, A. Kungu, D. Gatei, Suporn Silpisoronkosol, Tieng Pardthaisong, Virote Sahapong, Choti Theetranont, Banpot Boosiri, Supawat Chutivongse, Pramuan Virutmasen, Chansuda Wongsrchanalai, Sermsri Sindhvananda, Suporn Koetsawang, Daungdao Rachawat, Amom Koetsawang, P. P. Anthony, David B. Thomas, Elizabeth A. Noonan, Roberta M. Ray, Karin A. Rosenblatt, Janet L. Stanford, Susan Holck, Timothy M.M. Farley
• 其他作者: Chiang Mai University
• 格式: Article
• 出版: 2018
• 主題: Biochemistry, Genetics and Molecular Biology; Medicine
• 在線閱讀: https://repository.li.mahidol.ac.th/handle/123456789/22015

A hospital‐based case‐control study was conducted to assess the possible relationship between use of depot‐medroxy‐progesterone acetate (DMPA), an injectable progestational contraceptive, and the development of liver cancer in 2 developing countries where hepatitis B is endemic. Information about pr...